NYSE:PRGO - Perrigo Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $52.00
  • Forecasted Upside: 24.73 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$41.69
▲ +0.07 (0.17%)
1 month | 3 months | 12 months
Get New Perrigo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRGO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRGO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$52.00
▲ +24.73% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Perrigo in the last 3 months. The average price target is $52.00, with a high forecast of $63.00 and a low forecast of $45.00. The average price target represents a 24.73% upside from the last price of $41.69.
Hold
The current consensus among 4 investment analysts is to hold stock in Perrigo. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$51.00Medium
i
3/11/2021Morgan StanleyLower Price TargetEqual Weight$53.00 ➝ $45.00Low
i
3/5/2021Morgan StanleyLower Price TargetEqual Weight$53.00 ➝ $45.00Low
i
1/6/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$59.00 ➝ $49.00N/A
i
10/28/2020Wells Fargo & CompanyLower Price TargetEqual Weight$55.00 ➝ $49.00Low
i
9/17/2020SVB LeerinkLower Price TargetOutperform$64.00 ➝ $63.00High
i
Rating by A. Fadia at SVB Leerink LLC
6/8/2020SVB LeerinkBoost Price TargetOutperform$55.00 ➝ $63.00High
i
Rating by A. Fadia at SVB Leerink LLC
6/7/2020Royal Bank of CanadaReiterated RatingBuyHigh
i
Rating by Randall Stanicky at Royal Bank of Canada
4/17/2020ArgusDowngradeBuy ➝ HoldHigh
i
4/2/2020Morgan StanleyLower Price TargetEqual Weight$54.00 ➝ $53.00High
i
4/1/2020Royal Bank of CanadaReiterated RatingBuy$58.00High
i
Rating by Randall Stanicky at Royal Bank of Canada
3/24/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$57.00Medium
i
3/20/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$54.00 ➝ $52.00High
i
Rating by A. Fadia at SVB Leerink LLC
3/18/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$58.00High
i
3/11/2020Wells Fargo & CompanyLower Price TargetEqual Weight$63.00 ➝ $53.00High
i
Rating by David Maris at Wells Fargo & Company
2/28/2020Royal Bank of CanadaLower Price TargetSector Perform$64.00 ➝ $58.00High
i
1/21/2020Cantor FitzgeraldBoost Price TargetOverweight$60.00 ➝ $70.00Medium
i
10/11/2019ArgusUpgradeHold ➝ BuyLow
i
9/30/2019Wells Fargo & CompanyBoost Price TargetMarket Perform$45.00 ➝ $52.00Medium
i
Rating by David Maris at Wells Fargo & Company
9/25/2019SunTrust BanksBoost Price TargetHold$51.00 ➝ $55.00Medium
i
7/2/2019Wells Fargo & CompanyReiterated RatingHoldLow
i
Rating by David Maris at Wells Fargo & Company
6/19/2019Wells Fargo & CompanySet Price TargetHold$45.00High
i
Rating by David Maris at Wells Fargo & Company
6/12/2019Cantor FitzgeraldLower Price TargetOverweight$107.00 ➝ $60.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/20/2019SunTrust BanksBoost Price TargetHold$51.00Medium
i
5/8/2019Cantor FitzgeraldReiterated RatingBuy$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
4/4/2019SunTrust BanksLower Price TargetHold$46.00High
i
3/26/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$67.00 ➝ $54.00High
i
Rating by David Risinger at Morgan Stanley
3/19/2019SunTrust BanksInitiated CoverageHold ➝ Hold$51.00Medium
i
2/28/2019Royal Bank of CanadaSet Price TargetHold$48.00Medium
i
Rating by Randall Stanicky at Royal Bank of Canada
2/28/2019Wells Fargo & CompanySet Price TargetHold$47.00Medium
i
Rating by David Maris at Wells Fargo & Company
1/4/2019Royal Bank of CanadaSet Price TargetHold$50.00High
i
Rating by Randall Stanicky at Royal Bank of Canada
12/30/2018Wells Fargo & CompanySet Price TargetHold$46.00Low
i
Rating by David Maris at Wells Fargo & Company
12/30/2018Morgan StanleySet Price TargetHold$67.00Low
i
Rating by David Risinger at Morgan Stanley
12/24/2018SVB LeerinkLower Price Target$70.00 ➝ $56.00Medium
i
12/23/2018Morgan StanleySet Price TargetHold$67.00Medium
i
Rating by David Risinger at Morgan Stanley
12/21/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$64.00 ➝ $46.00High
i
Rating by David Maris at Wells Fargo & Company
12/20/2018Cantor FitzgeraldSet Price TargetBuy PRGO$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
11/14/2018Wells Fargo & CompanyLower Price TargetMarket Perform$77.00 ➝ $64.00Low
i
Rating by David Maris at Wells Fargo & Company
11/13/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$77.00 ➝ $67.00Low
i
Rating by David Risinger at Morgan Stanley
11/13/2018Berenberg BankDowngradeBuy ➝ Hold$100.00 ➝ $72.00Low
i
Rating by Patrick Trucchio at Berenberg Bank
11/9/2018Royal Bank of CanadaSet Price TargetHold$63.00Medium
i
Rating by Randall Stanicky at Royal Bank of Canada
10/8/2018Cantor FitzgeraldReiterated RatingBuy$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
8/21/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$84.00 ➝ $77.00Low
i
Rating by David Maris at Wells Fargo & Company
8/17/2018Canaccord GenuitySet Price TargetBuy$90.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
8/10/2018Jefferies Financial GroupReiterated RatingHold$73.00Low
i
8/10/2018JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$83.00 ➝ $75.00N/A
i
8/10/2018Royal Bank of CanadaLower Price TargetSector Perform ➝ Hold$89.00 ➝ $67.00N/A
i
Rating by Randall Stanicky at Royal Bank of Canada
8/10/2018Stifel NicolausLower Price TargetHold$92.00 ➝ $87.00Low
i
8/10/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$93.00 ➝ $78.00Low
i
8/9/2018Cantor FitzgeraldSet Price TargetBuy$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
7/30/2018ArgusDowngradeBuy ➝ HoldMedium
i
7/18/2018Cantor FitzgeraldReiterated RatingBuy$107.00Medium
i
Rating by L. Chen at Cantor Fitzgerald
7/12/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$78.00 ➝ $74.00Low
i
6/22/2018Cantor FitzgeraldReiterated RatingOverweightLow
i
Rating by L. Chen at Cantor Fitzgerald
6/18/2018Morgan StanleyReiterated RatingEqual Weight$85.00Low
i
6/6/2018BarclaysDowngradeOverweight ➝ Equal Weight$110.00Low
i
5/23/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/14/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
5/14/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/14/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$90.00 ➝ $84.00High
i
5/11/2018OppenheimerSet Price TargetBuy$98.00Low
i
Rating by Christopher Liu at Oppenheimer Holdings Inc.
5/8/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
4/23/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
4/16/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
4/9/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
3/26/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
3/12/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
3/5/2018OppenheimerSet Price TargetBuy$98.00Low
i
Rating by Derek Archila at Oppenheimer Holdings Inc.
3/5/2018JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Neutral$82.00 ➝ $83.00Low
i
3/5/2018Canaccord GenuitySet Price TargetBuy$105.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
3/1/2018Cantor FitzgeraldSet Price TargetBuy$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
2/27/2018Canaccord GenuitySet Price TargetBuy$105.00Medium
i
Rating by Dewey Steadman at Canaccord Genuity
2/27/2018OppenheimerReiterated RatingBuy$98.00High
i
Rating by Derek Archila at Oppenheimer Holdings Inc.
2/23/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
2/16/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
2/9/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
2/1/2018Berenberg BankInitiated CoverageBuy$117.00Low
i
1/19/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/17/2018Canaccord GenuityReiterated RatingBuy$100.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
1/12/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/5/2018Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
1/2/2018SVB LeerinkInitiated CoverageMkt Perform ➝ Market Perform$90.00Low
i
Rating by A. Fadia at SVB Leerink LLC
1/1/2018Canaccord GenuitySet Price TargetBuy$100.00High
i
Rating by Dewey Steadman at Canaccord Genuity
12/28/2017Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/26/2017Canaccord GenuitySet Price TargetBuy$100.00Low
i
Rating by Dewey Steadman at Canaccord Genuity
12/22/2017Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/16/2017Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/10/2017Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/8/2017ArgusUpgradeHold ➝ Buy$93.00Medium
i
12/4/2017Cantor FitzgeraldSet Price TargetBuy$107.00High
i
Rating by Louise Chen at Cantor Fitzgerald
12/4/2017BarclaysBoost Price TargetOverweight$93.00Medium
i
11/28/2017Cantor FitzgeraldSet Price TargetBuy$107.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
11/15/2017Cantor FitzgeraldSet Price TargetBuy$107.00N/A
i
Rating by Louise Chen at Cantor Fitzgerald
11/10/2017Jefferies Financial GroupReiterated RatingHold$81.00N/A
i
11/10/2017Wells Fargo & CompanyBoost Price TargetMarket Perform$90.00N/A
i
11/10/2017Morgan StanleyBoost Price TargetEqual Weight$79.00 ➝ $92.00N/A
i
11/10/2017Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$64.00 ➝ $86.00N/A
i
11/9/2017Cantor FitzgeraldReiterated RatingBuy$107.00N/A
i
10/29/2017Jefferies Financial GroupSet Price TargetHold$71.00N/A
i
10/20/2017Cantor FitzgeraldSet Price TargetBuy$107.00N/A
i
10/5/2017UBS GroupReiterated RatingBuy ➝ Buy$84.00 ➝ $98.00N/A
i
10/2/2017OppenheimerInitiated CoverageBuy$88.00Low
i
9/14/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$88.00 ➝ $95.00Low
i
9/13/2017Royal Bank of CanadaReiterated RatingSell$64.00Low
i
9/13/2017Canaccord GenuityReiterated RatingBuy$88.00 ➝ $100.00Low
i
9/12/2017Cantor FitzgeraldBoost Price TargetOverweight$93.00 ➝ $107.00Low
i
9/7/2017CIBCInitiated CoverageOutperform ➝ Outperform$88.00Low
i
9/7/2017OppenheimerInitiated CoverageOutperform$88.00High
i
8/21/2017Cantor FitzgeraldReiterated RatingBuyLow
i
8/15/2017Wells Fargo & CompanyReiterated RatingMarket Perform$77.00Low
i
8/11/2017Stifel NicolausReiterated RatingHoldLow
i
8/11/2017Jefferies Financial GroupReiterated RatingHold$69.00 ➝ $71.00Low
i
8/11/2017Royal Bank of CanadaBoost Price TargetUnderperform$60.00 ➝ $64.00Medium
i
8/11/2017The Goldman Sachs GroupUpgradeSell ➝ Neutral$66.00 ➝ $79.00Medium
i
8/10/2017Cantor FitzgeraldSet Price TargetBuy$85.00 ➝ $93.00Low
i
8/10/2017Canaccord GenuityReiterated RatingBuy$80.00 ➝ $88.00High
i
7/24/2017Cantor FitzgeraldSet Price TargetBuy$85.00Low
i
7/17/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$86.00 ➝ $88.00High
i
7/16/2017Royal Bank of CanadaSet Price TargetSell$60.00High
i
6/16/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$85.00Low
i
6/5/2017Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$66.00 ➝ $60.00Low
i
6/1/2017BarclaysReiterated RatingOverweight$100.00 ➝ $85.00Low
i
5/31/2017Canaccord GenuitySet Price TargetBuy$80.00Low
i
5/31/2017The Goldman Sachs GroupReiterated RatingSell$68.00High
i
5/24/2017Royal Bank of CanadaReiterated RatingHold$66.00Low
i
5/24/2017Jefferies Financial GroupReiterated RatingHold$71.00Medium
i
5/22/2017Canaccord GenuitySet Price TargetBuy$86.00Low
i
5/3/2017Royal Bank of CanadaReiterated RatingHold$68.00Low
i
4/22/2017B. RileyReiterated RatingNeutral$67.00Medium
i
4/19/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$87.00 ➝ $86.00Low
i
4/14/2017Wells Fargo & CompanyReiterated RatingMarket Perform$67.00N/A
i
3/18/2017Canaccord GenuitySet Price TargetBuy$86.00Medium
i
3/14/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$93.00 ➝ $87.00Low
i
3/8/2017B. RileyReiterated RatingNeutral$67.00Low
i
3/3/2017B. RileyReiterated RatingNeutral ➝ Neutral$83.00 ➝ $67.00N/A
i
3/1/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$95.00 ➝ $93.00N/A
i
2/28/2017Jefferies Financial GroupSet Price TargetHold$70.00 ➝ $71.00N/A
i
2/28/2017GuggenheimReiterated RatingBuy$125.00N/A
i
2/28/2017Royal Bank of CanadaLower Price Target$68.00N/A
i
2/28/2017Canaccord GenuityBoost Price TargetBuy$97.00 ➝ $100.00N/A
i
2/27/2017Royal Bank of CanadaReiterated RatingSector Perform$80.00N/A
i
2/21/2017Canaccord GenuityInitiated CoverageBuy ➝ Buy$100.00N/A
i
2/6/2017BarclaysLower Price TargetOverweight$110.00 ➝ $100.00N/A
i
2/6/2017GuggenheimReiterated RatingBuy$125.00N/A
i
1/30/2017The Goldman Sachs GroupReiterated RatingSellN/A
i
1/29/2017B. RileyReiterated RatingNeutral$83.00N/A
i
1/24/2017B. RileyReiterated RatingNeutral$83.00N/A
i
1/24/2017GuggenheimReiterated RatingBuy$125.00N/A
i
1/23/2017Jefferies Financial GroupLower Price TargetHold$84.00 ➝ $70.00N/A
i
1/17/2017Royal Bank of CanadaReiterated RatingSector Perform$92.00 ➝ $85.00N/A
i
1/17/2017Royal Bank of CanadaLower Price TargetSector Perform$92.00 ➝ $85.00N/A
i
12/23/2016GuggenheimReiterated RatingBuy$125.00N/A
i
11/16/2016B. RileyReiterated RatingNeutral$97.00N/A
i
11/11/2016B. RileyReiterated RatingNeutral$87.00 ➝ $97.00N/A
i
11/11/2016Bank of AmericaUpgradeUnderperform ➝ NeutralN/A
i
11/10/2016JPMorgan Chase & Co.Set Price TargetHold$95.00N/A
i
11/10/2016UBS GroupSet Price TargetBuy$110.00N/A
i
10/24/2016Royal Bank of CanadaSet Price TargetHold$92.00N/A
i
9/27/2016ArgusReiterated RatingHoldN/A
i
9/20/2016Royal Bank of CanadaReiterated RatingSector Perform$92.00N/A
i
9/15/2016GuggenheimSet Price TargetBuy$125.00N/A
i
9/13/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$105.00N/A
i
8/22/2016GuggenheimReiterated RatingBuy$125.00N/A
i
8/20/2016B. RileyReiterated RatingNeutral$87.00N/A
i
8/15/2016B. RileyReiterated RatingNeutral$87.00N/A
i
8/13/2016UBS GroupReiterated RatingBuy$120.00 ➝ $110.00N/A
i
8/13/2016JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
8/11/2016Jefferies Financial GroupLower Price TargetHold$97.00 ➝ $84.00N/A
i
8/11/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$115.00 ➝ $105.00N/A
i
8/11/2016BarclaysLower Price TargetOverweight$120.00 ➝ $110.00N/A
i
8/11/2016JPMorgan Chase & Co.Set Price TargetHold$105.00 ➝ $90.00N/A
i
8/11/2016Northland SecuritiesDowngradeOutperform ➝ Market Perform$123.00 ➝ $94.00N/A
i
8/10/2016SVB LeerinkSet Price TargetHold$96.00 ➝ $81.00N/A
i
7/22/2016Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$115.00N/A
i
7/8/2016UBS GroupReiterated RatingNeutral$169.00 ➝ $120.00N/A
i
7/3/2016B. RileyReiterated RatingNeutral$101.00N/A
i
6/28/2016B. RileyReiterated RatingNeutral$101.00N/A
i
6/20/2016ArgusDowngradeBuy ➝ HoldN/A
i
6/17/2016BTIG ResearchReiterated RatingNeutralN/A
i
6/15/2016Raymond JamesReiterated RatingHoldN/A
i
6/15/2016Bank of AmericaReiterated RatingSell$109.00N/A
i
6/3/2016Royal Bank of CanadaReiterated RatingSector Perform$109.00N/A
i
5/25/2016Royal Bank of CanadaReiterated RatingSector Perform$109.00N/A
i
5/18/2016B. RileyReiterated RatingNeutral$101.00N/A
i
Rating by Linda Bolton Weiser at B. Riley
5/14/2016Morgan StanleyReiterated RatingHoldN/A
i
Rating by David Risinger at Morgan Stanley
5/14/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Jason Gerberry at SVB Leerink LLC
5/13/2016B. RileyReiterated RatingNeutral$101.00N/A
i
Rating by Linda Bolton Weiser at B. Riley
5/13/2016Jefferies Financial GroupLower Price TargetHold$112.00 ➝ $97.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
5/12/2016UBS GroupReiterated RatingBuy$169.00N/A
i
4/30/2016B. RileyReiterated RatingNeutral$113.00N/A
i
Rating by Linda Bolton Weiser at B. Riley
4/27/2016UBS GroupReiterated RatingBuy$169.00N/A
i
4/26/2016The Goldman Sachs GroupReiterated RatingSell$124.00 ➝ $95.00N/A
i
4/26/2016Jefferies Financial GroupDowngradeHold$112.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
4/26/2016JPMorgan Chase & Co.Lower Price TargetNeutral$145.00 ➝ $105.00N/A
i
Rating by Chris Schott at JPMorgan Chase & Co.
4/26/2016Morgan StanleyLower Price TargetEqual Weight$151.00 ➝ $112.00N/A
i
Rating by David Risinger at Morgan Stanley
4/26/2016BarclaysLower Price TargetOverweight$180.00 ➝ $120.00N/A
i
Rating by Douglas Tsao at Barclays PLC
4/26/2016Royal Bank of CanadaLower Price TargetSector Perform$140.00 ➝ $109.00N/A
i
4/25/2016B. RileyReiterated RatingNeutral$146.00 ➝ $113.00N/A
i
Rating by Linda Bolton Weiser at B. Riley
4/25/2016Bank of AmericaDowngradeBuy ➝ UnderperformN/A
i
4/25/2016Stifel NicolausDowngradeBuy ➝ HoldN/A
i
Rating by Annabel Samimy at Stifel Nicolaus
4/25/2016BTIG ResearchDowngradeBuy ➝ NeutralN/A
i
4/25/2016Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$172.00 ➝ $120.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
4/25/2016GuggenheimReiterated RatingBuy$185.00N/A
i
4/25/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
4/25/2016Royal Bank of CanadaReiterated RatingSector Perform$140.00 ➝ $109.00N/A
i
4/24/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$163.00 ➝ $112.00N/A
i
Rating by David Steinberg at Jefferies Financial Group Inc.
(Data available from 4/19/2016 forward)
Perrigo logo
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $41.69
$41.46
$41.94

50 Day Range

MA: $41.24
$40.15
$42.65

52 Week Range

Now: $41.69
$38.20
$58.83

Volume

27,689 shs

Average Volume

1,354,339 shs

Market Capitalization

$5.57 billion

P/E Ratio

N/A

Dividend Yield

2.31%

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Perrigo?

The following Wall Street sell-side analysts have issued stock ratings on Perrigo in the last twelve months: Morgan Stanley, Royal Bank of Canada, SVB Leerink LLC, TheStreet, and Wells Fargo & Company.
View the latest analyst ratings for PRGO.

What is the current price target for Perrigo?

4 Wall Street analysts have set twelve-month price targets for Perrigo in the last year. Their average twelve-month price target is $52.00, suggesting a possible upside of 24.9%. SVB Leerink LLC has the highest price target set, predicting PRGO will reach $63.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $45.00 for Perrigo in the next year.
View the latest price targets for PRGO.

What is the current consensus analyst rating for Perrigo?

Perrigo currently has 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PRGO, but not buy more shares or sell existing shares.
View the latest ratings for PRGO.

What other companies compete with Perrigo?

How do I contact Perrigo's investor relations team?

Perrigo's physical mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company's listed phone number is 353-1709-4000 and its investor relations email address is [email protected] The official website for Perrigo is www.perrigo.com.